| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Molecular Pathology Program* and Histology and Immunohistochemistry Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid; the Departments of Pathology¶ and Dermatology, Hospital Universitario, 12 de Octubre, Madrid; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid; and MDS Pharma Services,|| Madrid, Spain
Cutaneous malignant melanoma remains the leading cause of skin cancer death in industrialized countries. Clinical and histological variables that predict survival, such as Breslow’s index, tumor size, ulceration, or vascular invasion have been identified in malignant melanoma. Nevertheless, the potential relevance of biological variables still awaits an in-depth exploration. Using tissue microarrays (TMAs), we retrospectively analyzed 165 malignant melanoma samples from 88 patients corresponding to distinct histological progression phases, radial, vertical, and metastases. A panel of 39 different antibodies for cell cycle, apoptosis, melanoma antigens, transcription factors, DNA mismatch repair, and other proteins was used. Integrating the information, the study has identified expression profiles distinguishing specific melanoma progression stages. Most of the detected alterations were linked to the control of cell cycle G1/S transition; cyclin D1 was expressed in radial cases 48% (12 of 25) with significant lost of expression in vertical cases 14% (9 of 65), P = 0.002; whereas p16INK4a (89% in vertical versus 71% in metastatic cases, P = 0.009) and p27KIP1 (76% in radial versus 45% in vertical cases, P = 0.010) were diminished in advanced stages. The study also defines a combination of biological markers associated with shorter overall survival in patients with vertical growth phase melanoma, that provided a predictor model with four antibodies (Ki67, p16INK4a, p21CIP1, and Bcl-6). This predictor model was validated using an independent series of 72 vertical growth phase melanoma patients.
This article has been cited by other articles:
 |
|
 |
|
  B. E. G. Rothberg, M. B. Bracken, and D. L. Rimm Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis J Natl Cancer Inst, April 1, 2009; 101(7): 452 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Klatte, D. B. Seligson, J. LaRochelle, B. Shuch, J. W. Said, S. B. Riggs, N. Zomorodian, F. F. Kabbinavar, A. J. Pantuck, and A. S. Belldegrun Molecular Signatures of Localized Clear Cell Renal Cell Carcinoma to Predict Disease-Free Survival after Nephrectomy Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 894 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Roodink, G. Kats, L. van Kempen, M. Grunberg, C. Maass, K. Verrijp, J. Raats, and W. Leenders Semaphorin 3E Expression Correlates Inversely with Plexin D1 During Tumor Progression Am. J. Pathol., December 1, 2008; 173(6): 1873 - 1881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Da Forno, J. H. Pringle, P. Hutchinson, J. Osborn, Q. Huang, L. Potter, R. A. Hancox, A. Fletcher, and G. S. Saldanha WNT5A Expression Increases during Melanoma Progression and Correlates with Outcome Clin. Cancer Res., September 15, 2008; 14(18): 5825 - 5832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Augustine, Y. Yoshimoto, M. Gupta, P. A. Zipfel, M. A. Selim, P. Febbo, A. M. Pendergast, W. P. Peters, and D. S. Tyler Targeting N-Cadherin Enhances Antitumor Activity of Cytotoxic Therapies in Melanoma Treatment Cancer Res., May 15, 2008; 68(10): 3777 - 3784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Renner, J. Fominaya, S. Alonso, C. Blanco-Aparicio, J. F.M. Leal, and A. Carnero Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate Carcinogenesis, July 1, 2007; 28(7): 1418 - 1425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Alonso, L. Tracey, P. Ortiz, B. Perez-Gomez, J. Palacios, M. Pollan, J. Linares, S. Serrano, A. I. Saez-Castillo, L. Sanchez, et al. A High-Throughput Study in Melanoma Identifies Epithelial-Mesenchymal Transition as a Major Determinant of Metastasis Cancer Res., April 1, 2007; 67(7): 3450 - 3460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Carreira, J. Goodall, L. Denat, M. Rodriguez, P. Nuciforo, K. S. Hoek, A. Testori, L. Larue, and C. R. Goding Mitf regulation of Dia1 controls melanoma proliferation and invasiveness Genes & Dev., December 15, 2006; 20(24): 3426 - 3439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Becker, M. C. Mihm, S. M. Hewitt, V. K. Sondak, J. W. Fountain, and M. Thurin Markers and Tissue Resources for Melanoma: Meeting Report. Cancer Res., November 15, 2006; 66(22): 10652 - 10657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Bertucci, D. Birnbaum, and A. Goncalves Proteomics of Breast Cancer: Principles and Potential Clinical Applications Mol. Cell. Proteomics, October 1, 2006; 5(10): 1772 - 1786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Gao, D. L. Dai, M. Martinka, and G. Li Prognostic Significance of Nuclear Factor-{kappa}B p105/p50 in Human Melanoma and Its Role in Cell Migration. Cancer Res., September 1, 2006; 66(17): 8382 - 8388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Miller and M. C. Mihm Jr. Melanoma. N. Engl. J. Med., July 6, 2006; 355(1): 51 - 65. [Full Text] [PDF]
|
|
|
|
 |
|
 R Bauer, P J Wild, S Meyer, F Bataille, A Pauer, M Klinkhammer-Schalke, F Hofstaedter, and A K Bosserhoff Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays J. Clin. Pathol., July 1, 2006; 59(7): 699 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tang, D. L. Dai, M. Su, M. Martinka, G. Li, and Y. Zhou Aberrant Expression of Collagen Triple Helix Repeat Containing 1 in Human Solid Cancers. Clin. Cancer Res., June 15, 2006; 12(12): 3716 - 3722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Scala, P. Giuliano, P. A. Ascierto, C. Ierano, R. Franco, M. Napolitano, A. Ottaiano, M. L. Lombardi, M. Luongo, E. Simeone, et al. Human Melanoma Metastases Express Functional CXCR4 Clin. Cancer Res., April 15, 2006; 12(8): 2427 - 2433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Gimotty, P. Van Belle, D. E. Elder, T. Murry, K. T. Montone, X. Xu, S. Hotz, S. Raines, M. E. Ming, P. Wahl, et al. Biologic and Prognostic Significance of Dermal Ki67 Expression, Mitoses, and Tumorigenicity in Thin Invasive Cutaneous Melanoma J. Clin. Oncol., November 1, 2005; 23(31): 8048 - 8056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Gimotty, J. Botbyl, S.-j. Soong, and D. Guerry A Population-Based Validation of the American Joint Committee on Cancer Melanoma Staging System J. Clin. Oncol., November 1, 2005; 23(31): 8065 - 8075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Grafstrom, S. Egyhazi, U. Ringborg, J. Hansson, and A. Platz Biallelic Deletions in INK4 in Cutaneous Melanoma Are Common and Associated with Decreased Survival Clin. Cancer Res., April 15, 2005; 11(8): 2991 - 2997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Tyler and C. M. Balch Nomograms and Staging in Melanoma: New Tools for Better Predicting Outcomes Ann. Surg. Oncol., April 1, 2005; 12(4): 267 - 269. [Full Text] [PDF]
|
|
|
|
|
|
J. Jacquemier, C. Ginestier, J. Rougemont, V.-J. Bardou, E. Charafe-Jauffret, J. Geneix, J. Adelaide, A. Koki, G. Houvenaeghel, J. Hassoun, et al. Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis Cancer Res., February 1, 2005; 65(3): 767 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nambiar, A. Mirmohammadsadegh, R. Doroudi, A. Gustrau, A. Marini, G. Roeder, T. Ruzicka, and U. R. Hengge Signaling Networks in Cutaneous Melanoma Metastasis Identified by Complementary DNA Microarrays Arch Dermatol, February 1, 2005; 141(2): 165 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Berger, R. L. Camp, K. A. DiVito, H. M. Kluger, R. Halaban, and D. L. Rimm Automated Quantitative Analysis of HDM2 Expression in Malignant Melanoma Shows Association with Early-Stage Disease and Improved Outcome Cancer Res., December 1, 2004; 64(23): 8767 - 8772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. DiVito, A. J. Berger, R. L. Camp, M. Dolled-Filhart, D. L. Rimm, and H. M. Kluger Automated Quantitative Analysis of Tissue Microarrays Reveals an Association between High Bcl-2 Expression and Improved Outcome in Melanoma Cancer Res., December 1, 2004; 64(23): 8773 - 8777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hoek, D. L. Rimm, K. R. Williams, H. Zhao, S. Ariyan, A. Lin, H. M. Kluger, A. J. Berger, E. Cheng, E. S. Trombetta, et al. Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas Cancer Res., August 1, 2004; 64(15): 5270 - 5282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M R Hussein Genetic pathways to melanoma tumorigenesis J. Clin. Pathol., August 1, 2004; 57(8): 797 - 801. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
